Avid Bioservices/CDMO

$7.44

-0.79%
-
1D1W1MYTD1YMAX

About Avid Bioservices

Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
Ticker
CDMO
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
Nicholas Green
Employees
365
Headquarters
Tustin, United States

Avid Bioservices Metrics

BasicAdvanced
$474.29M
Market cap
-
P/E ratio
-$0.18
EPS
1.65
Beta
-
Dividend rate

What the Analysts think about Avid Bioservices

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 4 analysts.
74.73% upside
High $16.00
Low $7.00
$7.44
Current price
$13.00
Average price target

Avid Bioservices Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-37.54% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$25.3M
-32.89%
Net income
$-9.5M
375%
Profit margin
-37.54%
608.3%

Avid Bioservices Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 140%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.01
-
-$0.03
-$0.15
-
Expected
-$0.04
$0.00
-$0.03
-$0.06
-$0.05
Surprise
-128.57%
-
9.09%
140%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Avid Bioservices stock

Buy or sell Avid Bioservices stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing